DOI QR코드

DOI QR Code

Anti-nociceptive and Anti-inflammatory Effects of Gami-cheongyulsaseub-tang in Arthritic Model

관절염 모델에서 가미청열사습탕(加味淸熱瀉濕湯)의 진통 및 소염 효과에 관한 연구

  • Received : 2014.12.26
  • Accepted : 2015.01.09
  • Published : 2015.02.28

Abstract

Objectives This study was carried out to find the effects of Gami-cheongyulsaseub-tang (hereinafter referred to GCST) on the inhibition of zymosan-induced pain in rats and collagen II-induced arthritis (CIA) in DBA/1J mouse. Methods As an acute inflammatory pain model, peripheral inflammation was induced by intraplantar injection of zymosan into the right hind paw in rats and then the hyperalgesia and pain regulating factors in spinal cord were analyzed. As a chronic inflammation model, the mixture of collagen II and complete Freund's adjuvant was treated into mice to establish rheumatoid arthritis and then body weight, thickness of hind paw, pathological change of spleen, immunological rheumatoid factor (IgG1, IgG2a, IgG2b, IgM and anti-collagen II), pro-inflammatory cytokines, and bone injury were analyzed. Results In the acute inflammatory pain model, GCST significantly inhibited the thermal and mechanical hyperalgesia and the pain regulating factors, including Fos, CD11b, PKA and PKC, in the spinal cord with a dose-dependent manner. In the chronic rheumatoid arthritis model, GCST administration decreased arthritic index and paw edema as compared with CIA control group. In particular, GCST reduced significantly the serum levels of total IgG2a, IgG2b, IgM, and specific anti-collagen II, but not total IgG1. GCST also resulted in the attenuation of bone injury and spleen enlargement/adhesion in CIA mice. Moreover, the secretion of pro-inflammatory cytokines TNF-${\alpha}$ and IL-$1{\beta}$ in CIA mice was significantly reduced by GCST in a dose-dependent manner. Conclusions Comparison of the results in this study showed that GCST had anti-nociceptive and immunomodulatory effects. These data imply that GCST can be used as an effective drug for not only rheumatoid arthritic pain but also other auto-immune diseases.

Keywords

Gami-cheongyulsaseub-tang (GCST);rheumatoid arthritis;pain;inflammation;collagen II;zymosan

References

  1. 한방재활의학과학회. 한방재활의학과학. 서울:군자출판사. 2005:78-99.
  2. 권영달, 송용선. 류머티스성 관절염(Rheumatoid arthritis)에 대한 동서의학적 고찰. 대한한의학회지. 1994;15(2):373-96.
  3. 이재동. 류마티스 관절염의 한방치료. 경희의학. 2004;20(1):4-9.
  4. 전국한의과대학 간계내과학교실. 간계내과학(2). 서울:동양의학연구원. 1992:532.
  5. Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev. 2003;(1):CD000189.
  6. Berkanovic E, Hurwicz M, O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350(25):2591-602. https://doi.org/10.1056/NEJMra040226
  7. Miyasaka N. Treatment trends of rheumatoid arthritis in Japan: Changes toward globalization and its unique innovation. Inflammation and Regeneration. 2011;31(1):25-32. https://doi.org/10.2492/inflammregen.31.25
  8. 沈金鰲. 沈氏尊生書. 臺北:自由出版社(卷13). 1972:745, 757.
  9. 성병곤, 박영일, 김재주, 김미선, 김남권, 임규상. Adjuvant에 의해 유발된 關節炎 白鼠모델에 있어서 大防風湯의 진통효과. 동의생리병리학회지. 2002;16(1):124-32.
  10. 최은실, 장홍규, 권오곤, 우창훈, 안희덕. Adjuvant 유발 관절염 랫트에 대한 삼기음의 효과. 한방재활의학과학회지. 2013;23(3):1-14.
  11. 윤순모, 정만진, 권오곤, 우창훈, 안희덕. Adjuvant 誘發 류마티스 關節炎에 대한 小活絡丹의 抑制 效果. 한방재활의학과학회지. 2011;21(1):97-114.
  12. 서윤정, 구성태, 양윤정, 김산, 유인식, 임규상. CFA에 의해 유도된 白鼠모델 關節炎에서 大羌活湯의 鎭痛效果. 대한경락경혈학회지. 2004;21(4):83-99.
  13. 이정민, 홍서영, 오민석. Papain으로 유도된 골관절염 생쥐 모델에서 芍藥甘草附子湯의 항골관절염 효능에 관한 연구. 大韓韓醫學會誌. 2013;34(1):116-35.
  14. 한을주, 이명종. 淸熱瀉濕湯이 관절염의 소염, 진통 및 해열작용에 미치는 영향. 한방재활의학과학회지. 2003;13(3):101-12.
  15. 조종철, 박종오, 이용구, 신현규, 김동희. CIA 생쥐의 關節炎 유발에 대한 淸熱瀉濕湯加味方의 억제 효과. 동의생리병리학회지. 2004;18(1):122-36.
  16. Visser H. Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2005;19(1):55-72. https://doi.org/10.1016/j.berh.2004.08.005
  17. Caughey GE1, Cleland LG, Penglis PS, Gamble JR, James MJ. Roles of cyclooxygenase(COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001;167(5):2831-8. https://doi.org/10.4049/jimmunol.167.5.2831
  18. 許俊. 東醫寶鑑. 서울:동의보감출판사. 2007:788.
  19. Kang SY, Yoon SY, Roh DH, Jeon MJ, Seo HS, Uh DK, Kwon YB, Kim HW, Han HJ, Lee HJ, Lee JH. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models. J Pharm Pharmacol. 2008;60(10):1347-54. https://doi.org/10.1211/jpp.60.10.0011
  20. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen : An experimental model of arthritis. J. Exp. Med. 1977;146(3):857-68. https://doi.org/10.1084/jem.146.3.857
  21. Firestein GS1, Paine MM, Boyle DL. Mechanism of methotrexate action in rheumatoid arthritis. Arthritis Rheum. 1994;37(2):193-200. https://doi.org/10.1002/art.1780370207
  22. 대한류마티스학회. 류마티스학. 서울:군자출판사. 2014:179.
  23. 대한내과학회 해리슨내과학 편집위원회 역. Harrison's 내과학 18판(2권). 서울:MIP. 2013:2692-704.
  24. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094-108. https://doi.org/10.1016/S0140-6736(10)60826-4
  25. Ito HO, So T, Ueda T, Imoto T, Koga T. Prevention of collagen induced arthritis by treatment with polyethylene glycolconjugated typeII collagen : distinct tolerogenic property of the conjugated collagen from the native one. Clin Exp Immunol. 1997;108(2):213-9. https://doi.org/10.1046/j.1365-2249.1997.3721269.x
  26. Burckhardt CS. The impact of arthritis on quality of life. Nurs Res. 1985;34(1):11-6.
  27. Schenck P, Schneider S, Miehlke R, Prehm P. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J. Rheumatol. 1995;22(3):400-5.
  28. De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004;63(12):1587-93. https://doi.org/10.1136/ard.2003.017574
  29. van Lent PL, Holthuysen AE, van den Bersselaar LA, van Rooijen N, Joosten LA, van de Loo FA, van de Putte LB, van den Berg WB. Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis. Arthritis Rheum. 1996;39(9):1545-55. https://doi.org/10.1002/art.1780390915
  30. 양유걸 편저. 황제내경소문역해. 대북:태련국풍출판사. 1984:95-6,326-36.
  31. 王燾. 外臺秘要方. 서울:대성문화사. 1983:424.
  32. 朱震亨. 丹溪心法(券四). 臺北:五洲出版社. 1981:708.
  33. 황문동. 실용중의내과학. 상해:상해과학기술출판사. 1986:554-69.
  34. 최용훈, 윤일지. 류마토이드 관절염의 연구동향에 대한 小考. 한방재활의학과학회지. 2009;19(2):125-56.
  35. 황종순, 김유종, 김은정, 조현석, 이승덕, 김갑성, 김경호. 유근피약침액이 Mouse 관절의 염증과 인지질 활성에 미치는 영향. 대한침구의학회지. 2012;29(3):55-65.
  36. 이승우, 김유종, 김은정, 이승덕, 김갑성, 윤종화. 농도별 봉독약침이 생쥐의 Type II Collagen 유발 관절염에 미치는 영향. 대한침구의학회지. 2012;29(1):75-87.
  37. 엄관준, 김지영, 김순중, 서일복, 정수현. 방풍통성산이 흰쥐의 Adjuvant 유발 관절염에 미치는 영향. 한방재활의학과학회지. 2012;22(2):91-103.
  38. 박진상, 한명금, 임양의, 이수경, 신병철, 권영달, 송용선. 생체외 류마토이드 관절염 실험 모델에서 淸熱瀉濕湯의 효과. 한방재활의학과학회지. 2004;14(2):29-30.
  39. 李鐘馨. 痛風. 醫林誌 155. 서울:醫林社. 1984:21-2.
  40. 金定濟. 診療要鑑(上). 서울:東洋醫學硏究院. 1974:459-60.
  41. 金永勳. 晴崗醫鑑. 서울:成輔社. 1984:315.
  42. 신민교. 본초학. 서울:영림사. 2006:411, 446, 723.
  43. 한종민, 신민교, 박호식. 백굴채의 약리작용에 관한연구. J Korean Med. 1985;6(2):128-33.
  44. 윤용갑, 김규민, 이성준, 유승훈, 장선일, 김민규. 금은화 수용성 추출물의 LPS유도 염증매개물 억제 효과. 대한본초학회지. 2007;22(3):117-25.
  45. 천순주, 조우아, 김영훈, 장민정, 성지연, 강보연, 최은영, 손준호, 백욱진, 이창언, 안봉전, 이진태. 浦公英의 항산화 및 화장품 약리학적 활성연구. 대한본초학회지. 2006;21(4):109-13.
  46. Sato M, Sano H, Iwaki D, Kudo K, Konishi M, Takahashi H, Takahashi T, Imaizumi H, Asai Y, Kuroki Y. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol. 2003;171(1):417-25. https://doi.org/10.4049/jimmunol.171.1.417
  47. Cabrera PV, Blanco G, Gravisaco MJ, Alvarez E, Hajos S. Zymosan modulates CD44 isoform expression in a murine model of inflammation resembling rheumatoid arthritis synovitis. J Rheumatol. 2001;28(5):943-9.
  48. Kang SY, Yoon SY, Roh DH, Jeon MJ, Seo HS, Uh DK, Kwon YB, Kim HW, Han HJ, Lee HJ, Lee JH. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models. J Pharm Pharmacol. 2008;60(10):1347-54. https://doi.org/10.1211/jpp.60.10.0011
  49. Cao H, Zhang YQ. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev. 2008;32(5):972-83. https://doi.org/10.1016/j.neubiorev.2008.03.009
  50. de Souza Nunes JP, da Silva KA, da Silva GF, Quintao NL, Correa R, Cechinel-Filho V, de Campos-Buzzi F, Niero R. The antihypersensitive and antiinflammatory activities of a benzofuranone derivative in different experimental models in mice: the importance of the protein kinase C pathway. Anesth Analg. 2014;119(4):836-46. https://doi.org/10.1213/ANE.0000000000000351
  51. Wang S, Dai Y, Fukuoka T, Yamanaka H, Kobayashi K, Obata K, Cui X, Tominaga M, Noguchi K. Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain. Brain. 2008;131(Pt 5):1241-51. https://doi.org/10.1093/brain/awn060
  52. Abbas AK, Lichtman AH. Celluar and Molecular Immunology. Seoul:Bummoonsa. 2004:185, 423.
  53. Varbanova BB, Baleva M, Nikolov K, Mihailova D. Prevalence of IgM, IgA and IgG-Rheumatoid Factors in Seronegative Polyarticular Disease Compared to Pauciarticular Disease in Juvenile Chronic Arthritis as Measured by ELISA. Adv Exp Med Biol. 1999;455:61-8. https://doi.org/10.1007/978-1-4615-4857-7_9
  54. 김진호, 한태륜. 재활의학. 서울:군자출판사. 2003:503.
  55. Lee KB. clinicopathologic handbook. Seoul:Komunsa. 2003:102-105, 233-235.
  56. The Korean society of pathologists. Pathology. Seoul: Komunsa. 1997:85, 1166-70, 1672.
  57. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet. 1989;2(8657):244-7.
  58. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun. 1999;265(1):144-50. https://doi.org/10.1006/bbrc.1999.1623

Acknowledgement

Supported by : 원광대학교